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Abstract
Background
Routine vaccination supplemented by planned campaigns occurring at 2–5 y intervals is
the core of current measles control and elimination efforts. Yet, large, unexpected out-
breaks still occur, even when control measures appear effective. Supplementing these
activities with mass vaccination campaigns triggered when low levels of measles immunity
are observed in a sample of the population (i.e., serosurveys) or incident measles cases
occur may provide a way to limit the size of outbreaks.
Methods and Findings
Measles incidence was simulated using stochastic age-structured epidemic models in set-
tings conducive to high or low measles incidence, roughly reflecting demographic contexts
and measles vaccination coverage of four heterogeneous countries: Nepal, Niger, Yemen,
and Zambia. Uncertainty in underlying vaccination rates was modeled. Scenarios with
case- or serosurvey-triggered campaigns reaching 20% of the susceptible population were
compared to scenarios without triggered campaigns. The best performing of the tested
case-triggered campaigns prevent an average of 28,613 (95% CI 25,722–31,505) cases
over 15 y in our highest incidence setting and 599 (95% CI 464–735) cases in the lowest
incidence setting. Serosurvey-triggered campaigns can prevent 89,173 (95% CI, 86,768–
91,577) and 744 (612–876) cases, respectively, but are triggered yearly in high-incidence
settings. Triggered campaigns reduce the highest cumulative incidence seen in simulations
by up to 80%. While the scenarios considered in this strategic modeling exercise are reflec-
tive of real populations, the exact quantitative interpretation of the results is limited by the
simplifications in country structure, vaccination policy, and surveillance system perfor-
mance. Careful investigation into the cost-effectiveness in different contexts would be
essential before moving forward with implementation.
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Conclusions
Serologically triggered campaigns could help prevent severe epidemics in the face of epi-
demiological and vaccination uncertainty. Hence, small-scale serology may serve as the
basis for effective adaptive public health strategies, although, in high-incidence settings,
case-triggered approaches are likely more efficient.
Author Summary
Why Was This Study Done?
• Large, unexpectedmeasles outbreaks continue to occur, even in settings where control
measures appear effective.
• Currently, large-scale vaccination campaigns that occur at regular 2–5 y intervals are a
key element of control in many settings.
• Work on outbreak response vaccination suggests that triggering campaigns in response
to information about the epidemiological context of the population could help avert
cases, but the appropriate design and impact of such campaigns were unclear.
What Did the Researchers Do and Find?
• The researchers developedmathematical models of measles dynamics reflective of a
range of demographic settings, and then simulated control strategies that included vacci-
nation campaigns launched in response to triggers such as a threshold number of cases
or the immune status of the population in a sentinel age group (as measured in a small
serological survey).
• Results showed that, across a range of settings, serologically triggered campaigns could
reduce incidence and prevent the most severe epidemics.
• However, in high-incidence settings, triggered campaigns may occur so often as to
become essentially routine activities (in which case planned activities may be more
appropriate).
What Do These Findings Mean?
• Triggered campaigns might provide a powerful addition to the current landscape of pub-
lic health and one of particular relevance as measles control is strengthened.
• Local context must be carefully considered when deciding on the best use of triggered
campaigns.
Performance of Triggered Campaigns in Minimizing the Impact of Epidemic Measles
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Introduction
Measles remains a leading cause of death among young children in low-income countries,
despite considerable progress over the last decade [1]. The major measles control activities in
addition to routine vaccination are supplemental immunization activities (SIAs), i.e., periodic
national or regional campaigns aimed at providing vaccine to everyone in a defined age range
[2]. Ultimately, the core solution to measles control lies in routine vaccination with at least two
doses of measles-containing vaccine (MCV) but, in much of the world, SIAs are relied upon to
achieve adequate coverage. However, even countries thought to have highly successful control
sometimes experience large outbreaks because of unnoticed buildups of susceptible individuals,
as recently occurred in countries such as Zambia, Malawi, and Burkina Faso [3].
The 2009WHO guidelines for outbreak response in mortality reduction settings and the
WHOGlobalMeasles and Rubella Strategic Plan for 2012–2014 extended the classic “static”
control strategies (routine immunization and SIAs occurring at intervals determined by the level
of routine coverage) to include the possibility of reactive responses [2,4]. Outbreak response vac-
cination (ORV) was recommended for outbreaks occurring in measles mortality reduction areas
[2], based on evidence that epidemics build sufficiently slowly that large numbers of cases can be
averted given a sufficiently prompt reaction [5–8]. ORV has also been recommended in elimina-
tion settings, where a single case should lead to appropriate outbreak investigation and response,
including vaccination of susceptible people in as wide an area as possible [9]. Identifying the
most effective strategies for outbreak response immunization activities has been posed as one of
the key issues in a recent review of research priorities for measles eradication [10]. However,
although there has been a range of quantitative analyses on the impact of varying characteristics
of static immunization strategies (e.g., the interval between SIAs) [11], investigations of the out-
comes of reactive vaccination coverage are rare. Ferrari and colleagues showed that ORV might
be key to reducing the case burden in the context of irregular, violent measles dynamics in Niger
[12]. This inferred impact of reactive vaccination echoes theoretical analyses showing that aver-
age outbreak size grows exponentially with the delay from the start of an outbreak to the imple-
mentation of an intervention [13,14]. Beyond these few analyses, little is known.
We propose that such reactive vaccination campaigns be considered as part of a larger class
of triggered campaigns (TCs). One could imagine a large number of reactive and prophylactic
triggers for such campaigns—for instance, triggers based on case detection,measures of popu-
lation immunity, or the recent performance of routine vaccination programs (many of these
triggers were invoked for the 1994 campaign in England andWales) [15,16]. Here we use sto-
chastic age-structured epidemic models to compare two TC strategies with the SIA/routine
vaccination combination that is currently in use.
Methods
Model Countries
We consider TC strategies in four hypothetical countries, representative of the demographics
andWHO-United Nations Children's Fund’s (UNICEF) (WHO/UNICEF Estimates of
National Immunization Coverage [WUENIC)) estimatedMCV1 vaccination coverage in areas
that are having varying success in measles control but have not achieved elimination.We
emphasize that these scenarios are selected to capture and exemplify the essence of realistic
regimes of demographics and measles control and are not intended to accurately represent any
particular country, population, or measles control program.
The hypothetical countries are (A) a moderate-birth-rate,moderate-coverage country (similar
to Yemen, 73%MCV1 coverage, 38 births per 1,000), (B) a high-birth-rate,moderate-coverage
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country (similar to Niger, 71%MCV1 coverage, 48 births per 1,000), (C) a lower-birth-rate,
moderately high-coverage country (similar to Nepal, 86%MCV1 coverage, 24 births per 1,000),
and (D) a high-birth-rate,moderately high-coverage country (similar to Zambia, 91%MCV1
coverage, 46 births per 1,000). Vaccination rates were roughly based on theWHO-UNICEF
adjusted estimates for 2014, except for Zambia, where the approximate 2009 rate was used to
illustrate a higher-coverage setting. The assumed birth rate, routine vaccine coverage, and popu-
lation pyramid for each exemplar country are shown in S1 Table. The populationmodeledwas
equivalent to the size of the capital cities of the exemplar countries, to capture the size of the pop-
ulation where the randommixing assumptions of the epidemicmodels usedmost nearly hold
and to avoid the need to account for geographic population structure in our results.
Intervention Scenarios
In each country, we assumed that routine coverage was constant at the hypothetical country
baseline or varied around that baseline as a random walk (see below). In all simulations, regu-
larly planned SIAs with 80% coverage of the target population of children between 9 and 59 mo
of age were modeled to occur every 5 y. Five years was selected as the maximum interval
between SIAs that would give each birth cohort (with the exception of those born in the 9 mo
prior to the SIA) two vaccination opportunities from the combination of routine vaccination
and regularly scheduled SIAs. As with the hypothetical countries, these scenarios are meant to
capture a not-implausible baseline intervention scenario that allows for comparison of TC strat-
egies whileminimizing the number of free (i.e., changeable) variables in the model (WHO rec-
ommendations are for SIAs every 2–4 y depending on routine vaccine program performance).
We compared this default control program with TCs triggered by the occurrence of N or
more cases in a bi-week (when<N occurred in the previous bi-week) or the measurement of
less than 85%measles seroprevalence in a sampled sentinel population. Based on informal dis-
cussions with colleagues at organizations working in measles control (e.g.,WHO and Médecins
Sans Frontières), case-based triggers of N = 10 and N = 25 were considered. Two sentinel popu-
lations were considered for seroprevalence studies: children from 24–36 mo of age and those
from 2–5 y of age. Each August (the low measles transmission season in our simulations), sero-
logical measurements were performed in a representative random sample of 200 individuals
from each sentinel population. Once a TC is triggered, there is a delay of 3 mo from the date of
the survey to allow for reporting and logistical delays (longer and shorter delays are considered
in a sensitivity analysis), and then a campaign is conducted that is assumed to reach 20% of the
hypothetical country’s unimmunized population who are 6–59 mo of age (i.e., though a much
higher percentage of the overall target population may receiveMCV in the TC, only 20% of
those who have not been previously successfully vaccinated will do so). The low effective cover-
age was selected to reflect the fact that such “just in time” campaigns are likely to be less effec-
tive at reaching previously unvaccinated populations than typical SIAs, as well as the difficulty
in reaching chronically unvaccinated populations (alternate coverages were examined in sensi-
tivity analyses) [17]. In subanalyses, we also consider the effect of targeting a wide age range (6
mo olds to 15 y olds), motivated by the wide age range of measles cases seen in some outbreaks
after a long period of successful control [18]. The measles vaccine is assumed to function as an
“all or nothing” vaccine (i.e., it induces full or no immunity), with vaccine effectiveness increas-
ing with age during the first year of life as specified in Lessler et al. [19]. In our models, those
without immunity after receiving a dose of vaccine have the same opportunity to be vaccinated
and protected in other rounds as if they had not previously received a dose of vaccine. Routine
vaccination is considered to reach the assumed level at 24 mo of age, with the age distribution
of coverage following the same pattern as was measured for Zambia in previous work [19].
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In further simulations, to capture realistic deviations from presumed routine coverage, we
implemented an autocorrelated random walk, designed to reflect a chosen variance, τ2, over
10 y. At every time-step, we generated a random deviate from a normal distribution with mean
0 and variance set to τ2 / [24 x 10]. If the probability density of this candidate value based on a
normal distribution with mean 0 and variance τ2 was greater than a random deviate from a
uniform distribution, the candidate was adopted; if not, the previous value was retained. The
true value of routine coverage at each time-step was obtained by increasing or reducing current
vaccination rates by this value. To capture realistic deviations from presumed SIA coverage, we
generated random deviates from a normal distribution with mean 0 and variance identical to
that used for routine vaccination; this was added to the presumed level of SIA coverage.
In addition to the default scenario described above, we considered alternate coverage levels
for TCs (10% and 40% of susceptibles covered), differing delays between a TC being triggered
and implemented (1 mo and 6 mo) and an alternate level for the case-based trigger (ten cases).
Simulations and Comparison
We performed stochastic simulations (200 for constant-routine vaccination-rate scenarios,
1,500 for varying-routine vaccination-rate scenarios) of each intervention scenario for each
country using a seasonally forced, age-structured time-series susceptible infected recovered
(TSIR) model, details of which can be found in Metcalf et al. (2012) [20]. Each simulation was
run for 20 y after the introduction of a single measles case in a fully susceptible population with
only routine vaccination and SIAs used for control. After these 20 y of “burn in,” additional
intervention strategies were introduced, and the simulation was run for an additional 15 y.
Intervention scenarios were compared based upon the total number of cases, the number of
cases averted, and the frequency at which TCs were triggered.
Additional methodological details are provided in S1 Text.
Results
For each country, we simulated time-series of measles incidence and critical vaccination events
for both the baseline scenario (no TCs, routine vaccination based on the country setting, and
SIAs every 5 y) and the baseline scenario plus TCs (case-basedor serologic) (Fig 1). The pro-
jected cumulative measles incidence in each scenario shows clear benefits from TCs compared
to static vaccination strategies (Fig 2). In Yemen- and Niger-like settings, where routine cover-
age is relatively low, serologically triggered campaigns prevent more cases than both case-
Fig 1. Typical time-series of incidence for three vaccination scenarios in a Yemen-like population: (i) a baseline scenario of
routine vaccination combined with SIAs every 5 y; (ii) this baseline combined with campaigns that are triggered by a threshold
number of cases; and (iii) this baseline combined with campaigns triggered by a threshold degree of serology in a target
population age range. Red lines indicate number of cases, green lines susceptibility in children under 5 y of age, dashed blue lines the
time of SIA occurrence, and dashed orange lines the timing of TCs.
doi:10.1371/journal.pmed.1002144.g001
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based triggers and no-TC scenarios (Figs 2 and 3). In Nepal- and Zambia-like countries, where
routine coverage is relatively high, TCs are generally better than the baseline case (no triggers),
but the benefits are less stark and are dwarfed by expected variation from stochastic variability.
In these situations, the expected benefits of all but the most sensitive serologically triggered
campaigns compared to case base methods are less clear.
Fig 3 shows the effects on cumulative case burden after 15 y of an array of different strategies
with different degrees of coverage and delays before TC implementation. Relative to the base-
line scenario (no triggers, vertical red line) the effect of TCs is considerably more marked in
contexts where baseline coverage is lower (e.g., Yemen-like countries), especially where a rea-
sonable degree of coverage can be attained in the TCs. However, an effect can be seen in all sce-
narios. In some contexts, monitoring only 2 y olds (24–36 mo of age) for higher levels of
susceptibility (15%) achieves similar outcomes to monitoring children aged 2–5 y with a more
sensitive cutoff (10%) and may be logistically easier.
The greater impact of TCs in low-coverage situations is largely the result of more frequent
TCs. In the Yemen-like situation, a sensitive serologic trigger (i.e., 10% susceptibility in chil-
dren) leads to TCs being conducted in 10 out of the first 15 y from policy implementation,
essentially becoming a routine event (Table 1, S1, S2 and S3 Tables). While case-triggered
Fig 2. Cumulative case burdens in (A) Yemen-like, (B) Niger-like, (C) Nepal-like, and (D) Zambia-like
populations for a range of different types of vaccination scenarios, where TCs are delayed by 3 mo
relative to the trigger and TC vaccination reaches 20% of the susceptible population.
doi:10.1371/journal.pmed.1002144.g002
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approaches lead to a smaller reduction in cumulative incidence, they occur far less frequently
and tend to result in more cases prevented per campaign in lower-coverage (Yemen-like) situa-
tions. In higher-coverage situations, serologically triggeredTCs occur far less often, and using
a sensitive susceptibility trigger of 10% appears to be able to greatly reduce the size of epidem-
ics. In these settings, case-based, or higher (15%) susceptibility, triggers have less impact.
The expected (i.e., average) effect of a reactive intervention on case burden is clearly of inter-
est; however, it may not be the most important public health outcome. Instead, we may be
more concernedwith preventing less common, but disastrous, large epidemics.While simula-
tions suggest a strong benefit of TCs in reducing the median simulated cumulative incidence
only in high-incidence (i.e., Yemen- and Niger-like) settings, TCs limit the size of the largest
epidemics seen in all settings. In simulations with stochasticity in underlying vaccination rates,
the most effective serology-basedTCs reduced the size of the largest epidemics seen (i.e., the
Fig 3. Median (point) and interquartile range (lines) of the cumulative case burden after 15 y for 200
simulations across a range of different vaccination scenarios (no trigger, case-based trigger, and
serological-based triggers) with different delays before the campaign can be deployed (1 mo, 3 mo,
and 6 mo), different coverage attained in the TCs (10%, 20%, or 40%), different degrees of sensitivity
in the serological surveys (10% or 15%), and different age ranges for the serological surveys
(children, aged 1 to 5 y; or infants, aged 24 to 36 mo). The baseline scenario (no trigger) is shown as a
vertical red line for each country.
doi:10.1371/journal.pmed.1002144.g003
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97.5th percentile of size) by 64% or more in all scenarios (Fig 4, S4 Fig). Hence, TCs may be
effective in preventing the worst epidemics in all settings. In low-incidence settings, case-based
approaches can be nearly as effective for preventing extremely large outbreaks as serological
approaches (Fig 4), although serological approaches are more effective overall.
Subanalyses in which TCs target 6 mo olds to 15 y olds show qualitatively similar results to
the main analysis (S2, S3, and S4 Figs, and S4 Table). Improvements are significant, for case-
trigger-basedTCs in high-incidence settings, in some instances preventing over 150% as many
Table 1. Mean total number of cases averted after 15 y across 1,500 simulations, with noisy vaccina-
tion trajectories and mean total number of TCs and cases averted per TC for vaccination scenarios
with the stated trigger, 20% coverage, and a 3-mo lag between trigger and vaccination.
Cases Averted (95%
CI)
Average Number of TCs (95%
CI)
Cases Averted per TC (95%
CI)
Yemen-like (73% routine coverage, 38 births per 1,000)
10 cases 27,705 (24,780–
30,631)
2.18 (2.10–2.25) 12,736 (11,322–14,150)
25 cases 28,613 (25,722–
31,505)
2.09 (2.02–2.16) 13,691 (12,223–15,158)
10% s in 2–5 y
olds
83,722 (81,247–
86,198)
9.81 (9.77–9.85) 8,537 (8,282–8,792)
15% s in 2–5 y
olds
68,084 (65,336–
70,832)
7.18 (7.13–7.24) 9,480 (9,090–9,869)
15% s in 2 y olds 89,173 (86,768–
91,577)
11.01 (10.97–11.06) 8,098 (7,877–8,319)
Niger-like (71% routine coverage, 48 births per 1,000)
10 cases 18,269 (16,363–
20,175)
2.12 (2.06–2.19) 8,612 (7,675–9,549)
25 cases 18,422 (16,479–
20,364)
1.95 (1.88–2.01) 9,470 (8,423–10,516)
10% s in 2–5 y
olds
52,718 (51,022–
54,414)
10.15 (10.11–10.20) 5,193 (5,024–5,362)
15% s in 2–5 y
olds
41,124 (39,280–
42,968)
7.53 (7.47–7.58) 5,463 (5,214–5,711)
15% s in 2 y olds 56,207 (54,570–
57,844)
11.45 (11.41–11.48) 4,910 (4,766–5,054)
Nepal-like (86% routine coverage, 24 births per 1,000)
10 cases 712 (571–852) 1.39 (1.32–1.46) 513 (408–617)
25 cases 582 (436–728) 0.91 (0.85–0.96) 640 (475–806)
10% s in 2–5 y
olds
1,093 (960–1226) 5.03 (4.98–5.09) 217 (191–244)
15% s in 2–5 y
olds
416 (258–574) 1.20 (1.16–1.25) 346 (214, 478)
15% s in 2 y olds 701 (554–848) 2.18 (2.12–2.24) 322 (254, 389)
Zambia-like (91% routine coverage, 46 births per 1,000)
10 cases 599 (464–735) 1.07 (1.01–1.13) 561 (430–692)
25 cases 459 (320–598) 0.74 (0.69–0.79) 621 (429–813)
10% s in 2–5 y
olds
744 (612–876) 3.72 (3.67–3.77) 200 (164–236)
15% s in 2–5 y
olds
108 (−70 to 285) 0.38 (0.35–0.41) 284 (−185 to 752)
15% s in 2 y olds 326 (174–479) 0.88 (0.83–0.92) 373 (197–549)
Abbreviations: s, seropositive
doi:10.1371/journal.pmed.1002144.t001
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cases, but tend to be less pronounced for serologically triggeredTCs and in low-incidence set-
tings, where in most instances differences are not significant.
Discussion
This analysis explored the impact of TCs across a range of demographic and measles vaccine
coverage contexts. We found that TCs consistently reduced the cumulative case burden. Fur-
thermore, in all settings, TCs were effective in preventing rare yet large and potentially most
damagingmeasles epidemics.We found that this positive impact is observed even for cam-
paigns reaching 20% or less of the unimmunized population, and the largest impact is observed
for serologically triggered surveys.Overall, however, the magnitude of the impact of TCs is
highly dependent on the demographic and vaccine coverage context considered. Some TC
strategies may be triggered so often that they become highly inefficient (i.e., few cases are pre-
vented per campaign). Consequently, our results suggest that although TCs could powerfully
strengthenmeasles control programs in some settings, they are not appropriate to all settings.
Fig 4. Percentiles (2.5, 25, 50, 75, and 97.5) of simulated (1,500 simulations, noisy vaccination rate)
15-y cumulative measles incidence under different intervention scenarios with 20% additional
coverage in (A) Yemen-like, (B) Niger-like, (C) Nepal-like, and (D) Zambia-like populations. Dark
vertical bars indicate the percent reduction in the largest (97.5th percentile) epidemics seen achieved by the
most effective intervention considered.
doi:10.1371/journal.pmed.1002144.g004
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Where routine coverage is relatively high and measles well controlled, as is the case in the
Nepal- and Zambia-like scenarios, case-based triggers are not very effective in terms of cases
averted per campaign (S1 Table). This is because when outbreaks occur, they will tend to be of
short duration, given the rarity of susceptibles, so that campaigns triggered by the start of any
outbreak will only avert a small number of cases. Serology-basedtriggers (essentially triggered
prophylactic vaccination) can help prevent outbreaks before they begin and thus prevent more
cases per campaign. This underlines the major potential benefits of susceptibilitymonitoring
as an effective form of risk management by serology, when logistically feasible [21]. However,
in low-incidence settings, both serology- and case-based approaches will rarely be triggered (in
many simulations for Zambia- and Nepal-like settings, no TC was triggered), but having a TC
program in place effectively avoids the worst outcomes in terms of large measles epidemics and
can provide a safeguard against the effects of overestimation of vaccination coverage in routine
programs or SIAs (Fig 4).
If measles is less well controlled, as in our Yemen- and Niger-like scenarios, serology-based
triggers would lead to a TC almost every year (Fig 1, Table 1, and S1 Table). This suggests that
rather than the additional investment in a serological survey every year, simply supplementing
routine vaccination by a yearly campaign might be more effective, if the required investment in
campaigns is considered acceptable. By contrast, case-triggeredcampaigns occurmuch less fre-
quently and are effective (though less so) in averting cases, as outbreaks tend to be of long dura-
tion. Case-basedTCs should consequently be the supplementary strategy of choice if resource
constraints mean that scheduled campaigns are not implemented often enough and that rou-
tine coverage is not increased.
Just as serology-basedcampaigns will be inefficient in contexts where measles is poorly con-
trolled, more broadly, any TC strategy will not be suitable for countries with particularly low
measles vaccination coverage and large yearly epidemics. In these settings, any TC trigger will
likely be activated every year, and the approach will cease to be one of TCs and will become
one of regular yearly supplemental vaccination activities covering a broad age range. While
such activities would undoubtedly aid in measles control, they would merely be a poorly
planned version of a strategy of yearly SIAs.
Serosurveys covering wider age ranges than considered here may capture some important
gaps in immunity in older age groups and better reflect relevant population susceptibility, but
may yield limited benefits over an ongoing program of regular serosurveys of a narrower age
group in which each cohort would have been surveyed at an earlier age. Targeting a small,
young age group will also increase power if the size of the serosurvey is limited, as an equal-
sized survey spread across larger age groups will have more noise and be less likely to detect
cohorts of high susceptibility. This higher sensitivity is one reason for the superior performance
of triggers focused on 24–36 mo olds in our simulations. However, if only young individuals
are tested, trends in serosurvey results year-to-year should be carefully tracked.
TCs remain a sparsely deployed public health strategy. Case-triggeredcampaigns are the
most common, particularly in situations in which elimination has been achieved (e.g., the
United States) [22]. For nonelimination situations, in low- and middle-income countries, a
recent review found that out of 461 outbreaks reported in the literature, only 38 referred to
case-triggeredcampaigns [7]. We could not identify any clear serologically triggered campaigns
(although serology contributed to the 1994 campaign in the United Kingdom [15,16] and led
to continued use of polio vaccine in US army recruits [DS Burke, personal communication]
[23]). Our results indicate that this might be a fruitful area for further development of public
health strategy. Having a TC strategy in place might be particularly useful in countries with
high (>90%) purported vaccination coverage, serving as a safeguard against accumulations of
immunity if routine SIAs are no longer considered to be needed.
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The costs of a TC program can be divided into three categories: (1) the cost of ongoing mon-
itoring, (2) the costs of conducting each campaign, and (3) the cost of having resources avail-
able to implement an emergency campaign. If surveillanceprograms are already robust, case-
based TC programs would incurminimal excess costs, if any; however, in countries where sur-
veillance is poor, small, highly targeted serosurveysmay actually be cheaper than system-wide
improvements in case detection (although the latter is needed in any case if countries are to
move towards elimination). The bulk of additional costs will come from campaigns themselves
and include direct costs such as vaccine doses, personnel, and equipment, as well as indirect
costs incurred from diverting resources from other health activities. These costs are propor-
tional to the number of campaigns performed; hence, they will be greatest when serosurvey-
based triggers are used in high-incidence settings. The costs of having resources at the ready
are potentially significant, but costs could be minimized by having a shared stockpile that
countries could draw from in an emergency (e.g., the International CoordinatingGroup oral
cholera vaccine stockpile).
Strategic modeling studies such as this require a balance of realism with abstraction and
generalization. Hence, there are many limitations in our study that affect the quantitative
interpretation of this analysis in relation to any particular country or setting. Countries were
assumed to have demographic, but not spatial, structure, and such spatial heterogeneities can
have a considerable effect on dynamics and campaign performance if certain areas are sys-
tematically missed.We used a highly simplifiedmodel of measles vaccination policy, and cur-
rent practice of basing the frequency and age-range of SIAs on routine vaccination program
performance and measles incidencemay achieve some of the reductions in incidence
achieved by TCs. Likewise, while the control strategies here are illustrative of those that
might be considered, they ignore some complexities (e.g., the proportion of cases detected by
surveillance) and are not optimized for each setting. Before implementing a TC-based strat-
egy, countries may want to perform additional analyses based on their measles control goals
and adjustfor the performance of their surveillance system. Even in simulation studies, it is
not practical to create a perfect counterfactual for every instance of an epidemic and control
strategy; hence, we can only compare strategies using aggregate statistics. Further, there is
currently very little data on the costs of implementation of the various components of a trig-
gered vaccination strategy, and further research is needed to evaluate the investment case for
TCs. Despite these limitations, our study provides insights into the potential effectiveness of
triggered control strategies and the context in which such strategies might or might not be
effective.
While our focus here was on measles in countries with stable vaccination programs, TC
campaigns may be relevant for other vaccines within the Expanded Program on Immunization.
One key advantage of expanding the programmight be that serological surveys could be com-
bined, maximizing returns on that investment, which our analysis also shows can be effective
even for relatively modest-sized surveys (e.g., 200 people in cities of 1–2 million). Likewise,
TCs may also play an important role in the pathway to elimination when routine vaccine cov-
erage is increasing, serving as a potential safeguard as SIAs are being phased out, and the opti-
mal use of TCs in such situations is an important area for future research. However, an
important caveat is that all TC strategies may be vulnerable to underlying heterogeneities in
case numbers or susceptibility profiles (for example, spatial heterogeneities within cities or
across countries), which may result in either too frequent or too rare triggering.The potential
for greater use of serologicalmonitoring of population susceptibility to vaccine-preventable
infections and its use both for triggering supplementary control activities and for monitoring
progress towards elimination targets needs further investigation.
Performance of Triggered Campaigns in Minimizing the Impact of Epidemic Measles
PLOS Medicine | DOI:10.1371/journal.pmed.1002144 October 11, 2016 11 / 14
Supporting Information
S1 Fig. Percentiles (2.5, 25, 50, 75, and 97.5) of simulated (200 simulations, constant vacci-
nation rate) 15-y cumulativemeasles incidence under different intervention scenarios in
(A) Yemen-like, (B) Niger-like, (C) Nepal-like, and (D) Zambia-like populations.Dark ver-
tical bars indicate the percent reduction in the largest (97.5th percentile) epidemics seen
achieved by the most effective intervention considered.
(TIF)
S2 Fig. Cumulative case burdens when TCs target 6 mo olds to 15 y olds in (A) Yemen-like,
(B) Niger-like, (C) Nepal-like, and (D) Zambia-like populations for a range of different
types of vaccination scenarios,where TCs are delayed by 3 mo relative to the trigger, and
TC vaccination reaches 20% of the unvaccinated population.
(TIF)
S3 Fig. When TCs target 6 mo olds to 15 y olds, median (point) and interquartile range
(lines) of the cumulative case burden after 15 y for 200 simulations across a range of differ-
ent vaccination scenarios (no trigger, case-basedtrigger, and serological-basedtriggers)
with different delays before the campaign can be deployed (1 mo, 3 mo, and 6 mo), differ-
ent coverage attained in the TCs (10%, 20%, or 40%), different degrees of sensitivity in the
serological surveys (10% or 15%), and different age ranges for the serological surveys (chil-
dren, aged 1 to 25 y; or infants, aged 24 to 36 mo). The baseline scenario (no trigger) is
shown as a vertical red line for each country.
(TIF)
S4 Fig. Percentiles (2.5, 25, 50, 75, 97.5) of simulated (200 simulations, constant vaccina-
tion rate) 15-y cumulativemeasles incidence under different intervention scenarioswhere
TCs target 6 mo olds to 15 y olds in (A) Yemen-like, (B) Niger-like, (C) Nepal-like, and (D)
Zambia-like populations.Dark vertical bars indicate the percent reduction in the largest
(97.5th percentile) epidemics seen achieved by the most effective intervention considered.
(TIF)
S1 Table. Birthrates, vaccination rates, and population pyramids for four scenarios.
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S2 Table. Mean number of cases averted after 15 y across 200 simulations,median total
number of TCs for the full range of vaccination scenarios, and their ratio, i.e., number of
cases averted per campaign.
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S3 Table. Mean number of cases averted after 15 y across 1,500 simulations with noisy vac-
cination trajectories,median total number of TCs for the full range of vaccination scenar-
ios, and their ratio, i.e., number of cases averted per campaign.
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S4 Table. Performance when TCs target 6 mo olds to 15 y olds.Columns are as follows:
mean total number of cases averted after 15 y across 200 simulations, mean total number of
TCs and cases averted per TC for vaccination scenarios with the stated trigger, 20% coverage,
and a 3-molag between trigger and vaccination.
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